|
2024
|
Invention
|
Rna-based strategies for dendritic cell reprogramming and uses thereof. The present invention rel... |
|
2022
|
G/S
|
Pharmaceutical preparations for the treatment of cancer; Pharmaceutical preparations for use in c... |
|
|
G/S
|
Pharmaceuticals. |
|
|
Invention
|
Reprogramming of cells to type 1 conventional dendritic cells or antigen-presenting cells.
The p... |
|
|
Invention
|
Reprogramming of cells to type 1 conventional dendritic cells or antigen-presenting cells. The pr... |
|
|
Invention
|
Compositions for reprogramming cells into dendritic cells or antigen presenting cells, methods an... |
|
2021
|
Invention
|
Compositions, constructs and vectors for cell reprogramming.
The present disclosure relates to c... |
|
2020
|
Invention
|
Compositions for reprogramming cells into dendritic cells type 2 competent for antigen presentati... |
|
|
Invention
|
Composition for reprogramming cells into plasmacytoid dendritic cells or interferon type i-produc... |
